FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

Fourth Quarterly Performance Report Released for the 2018-2019 Fiscal Year
August 23, 2019

The Quarterly Performance Report for the fourth quarter of the 2018-2019 fiscal year is now available online. Continue reading


Human Trafficking
July 10, 2019

Click here for new profession requirements and reporting procedures regarding Human Trafficking Continue reading